| Code | CSB-RA138082A0HU |
| Size | US$210 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
CDT1 serves as a critical licensing factor in DNA replication, functioning as an essential component of the pre-replicative complex that ensures each chromosomal region replicates exactly once per cell cycle. Its tight regulation through cell cycle-dependent degradation and interaction with geminin makes CDT1 a key focus in studies of genome stability, cell proliferation, and cancer biology, where dysregulation of replication licensing contributes to genomic instability.
This recombinant monoclonal antibody, generated from clone 8H5, offers the reproducibility and consistency that demanding research applications require. Because the antibody sequence is defined and produced recombinantly in rabbit host cells, you can expect uniform performance across experiments and over time, eliminating the lot-to-lot variability that can complicate long-term studies or multi-site collaborations.
Validated for Western blot applications, this antibody has demonstrated reliable detection of CDT1 in human cell lysates including HEK293, A431, and Jurkat cells at dilutions ranging from 1:500 to 1:2000. The observed band at approximately 70 kDa runs slightly higher than the predicted 60 kDa molecular weight, a shift commonly attributable to post-translational modifications such as phosphorylation or ubiquitination, both of which are known regulatory mechanisms for CDT1 during cell cycle progression.
Supplied in a glycerol-containing buffer optimized for long-term storage stability, this affinity-purified antibody is well-suited for researchers investigating DNA replication control, cell cycle checkpoints, or the molecular mechanisms underlying replication stress in cancer models.
There are currently no reviews for this product.